H‐Pro‐[3H]Leu‐Gly‐NH2: Uptake and Metabolism in Rat Brain
- 1 January 1982
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 38 (1) , 67-74
- https://doi.org/10.1111/j.1471-4159.1982.tb10854.x
Abstract
The uptake and metabolism of H-Pro-[3H]Leu-Gly-NH2 ([3H]PLG) in rat brain was investigated by reverse-phase paired-ion high pressure liquid chromatography. Following in vitro incubation of [3H]PLG with rat brain subcellular preparations, the microsomal-cytosol fraction was about twice as active in degrading PLG as the crude mitochondrial-synaptosomal fraction. For both enzyme preparations the pH optimum was found at pH 7–7.5. The major labeled metabolite was [3H]leucine, whereas 3H-labeled Leu-Gly-NH2 as the only labeled peptide intermediate was found in trace amounts. After intravenous injection of [3H]PLG the uptake of unmetabolized peptide in the brain appeared to be very low: 0.008% and 0.001% of the administered dose/g tissue at 2 and 5 min after injection respectively, while at longer survival times intact peptide was below the detection limit. Compared with the intravenous route of administration, intracerebroventricular injection of [3H]PLG yielded much higher brain concentrations of unmetabolized PLG. Following both routes of administration, the metabolite profile was in agreement with that obtained after in vitro incubation. However, the in vivo experiments also showed considerable incorporation of [3H]leucine liberated from [3H]PLG into proteins. Both the in vitro and in vivo results indicate that the initial cleavage of PLG in rat brain occurs at the NH2-terminus and that the dipeptide intermediate H-Leu-Gly-NH2 is subsequently hydrolyzed to its constituent amino acids very rapidly.Keywords
This publication has 35 references indexed in Scilit:
- Catabolism of neuropeptides by a brain proline endopeptidaseBiochemical and Biophysical Research Communications, 1980
- Development of narcotic tolerance and physical dependence: Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly)Pharmacology Biochemistry and Behavior, 1980
- Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amidePharmacology Biochemistry and Behavior, 1978
- Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependenceLife Sciences, 1976
- In vivo fate of a behaviorally active ACTH 4-9 analog in rats after systemic administrationPharmacology Biochemistry and Behavior, 1976
- Radioautographic localization of radioactivity in rat brain after intraventricular or intracarotid injection of 3H-L-prolyl-L-leucyl glycinamidePharmacology Biochemistry and Behavior, 1975
- DISTRIBUTION OF RADIOACTIVITY IN THE ORGANS OF THE RAT AND MOUSE AFTER INJECTION OF l-[3H]PROLYL-l-LEUCYL-GLYCINAMIDEJournal of Endocrinology, 1975
- PROTEIN AND PEPTIDE HYDROLASES OF THE RAT HYPOTHALAMUS AND PITUITARYJournal of Neurochemistry, 1974
- Evidence that Pro-Leu-Gly-NH2, tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormoneBiochemical and Biophysical Research Communications, 1973
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971